UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug Challenge Tests With General Anesthetics: Predictive Value of Skin Tests

Journal of investigational allergology & clinical immunology, 2020-01, Vol.30 (2), p.101-107

2020

Volltextzugriff (PDF)

Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response

Journal of investigational allergology & clinical immunology, 2019-01, Vol.29 (2), p.103-111

2019

Volltextzugriff (PDF)

Social Media as a Tool for the Management of Food Allergy in Children

Journal of investigational allergology & clinical immunology, 2018-01, Vol.28 (4), p.233-240

2018

Volltextzugriff (PDF)

Eosinophilic Esophagitis Caused by Grass Pollen Sublingual Immunotherapy With Tolerance to a Subcutaneous Extract

Journal of investigational allergology & clinical immunology, 2022-01, Vol.32 (4), p.315-317

2022

Volltextzugriff (PDF)

Is Self-injectable Epinephrine Being Used by Children With Food Allergy?

Journal of investigational allergology & clinical immunology, 2019-01, Vol.29 (6), p.461-463

2019

Volltextzugriff (PDF)

Differences in the Anaphylactic Response between C3H/HeOuJ and BALB/c Mice

International archives of allergy and immunology, 2017-01, Vol.173 (4), p.204-212

2017

Volltextzugriff (PDF)

One of the Faces of Facial Swelling: Melkersson-Rosenthal Syndrome

Journal of investigational allergology & clinical immunology, 2018-08, Vol.28 (4), p.265-267

2018

Volltextzugriff (PDF)

One of the Faces of Facial Swelling: Melkersson-Rosenthal Syndrome

Journal of investigational allergology & clinical immunology, 2018-01, Vol.28 (4), p.255

2018

Volltextzugriff (PDF)

Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients

Journal of investigational allergology & clinical immunology, 2021-04, Vol.31 (2), p.180-181

2021

Volltextzugriff (PDF)

Inhibition of Chronic Airway Inflammation and Remodeling by Galectin-3 Gene Therapy in a Murine Model

Journal of Immunology, 2006-02, Vol.176 (3), p.1943-1950

2006

Volltextzugriff (PDF)

Characterization of allergens secreted by Anisakis simplex parasite: clinical relevance in comparison with somatic allergens

Clinical and experimental allergy, 2004-02, Vol.34 (2), p.296-302

2004

Volltextzugriff (PDF)

Angioedema Induced By Angiotensin-converting Enzyme Inhibitors: Two Cases Of Successful Treatment With A Novel B2 Bradykinin Antagonist

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB105-AB105

2011

Volltextzugriff (PDF)

Preliminary study of the Craniofacial Pain and Disability Inventory-11: validation for patients with head and neck cancer

Medicina oral, patología oral y cirugía bucal, 2021-09, Vol.26 (5), p.e661-e668

2021

Volltextzugriff (PDF)

DNA-based immunotherapeutics for the treatment of allergic disease

Immunological reviews, 2001-02, Vol.179 (1), p.102-118

2001

Volltextzugriff (PDF)

Delayed Hypersensitivity Reaction to Lenalidomide: 2 Different Clinical Patterns in the Same Patient

Journal of investigational allergology & clinical immunology, 2019-08, Vol.29 (4), p.309-311

2019

Volltextzugriff (PDF)

Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population

ALLERGY, 2020, Vol.75, p.37

2020

Volltextzugriff (PDF)

ARTEMIS: A European, Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial of AR101 in Peanut-Allergic Children and Adolescents Aged 4-17

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, Vol.18, p.8

2020

Volltextzugriff (PDF)

Anisakis Simplex and Ascaris Lumbricoides Inhibit the Allergic Response to Peanut in a Murine Model of Anaphylaxis

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB28-AB28

2010

Volltextzugriff (PDF)

Allergic Response Modulation by Phytosterols in a Murine Model of Pollen Allergy

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB115-AB115

2010

Volltextzugriff (PDF)

ARTEMIS: a European, Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial of AR101 in peanut-allergic children and adolescents aged 4-17 years

CLINICAL AND EXPERIMENTAL ALLERGY, 2019, Vol.49 (12), p.1676

2019

Volltextzugriff (PDF)

ARTEMIS: A European, phase 3, randomised, double-blind, placebo-controlled trial of AR101 in peanut-allergic children and adolescents aged 4-17

ALLERGY, 2019, Vol.74, p.16

2019

Volltextzugriff (PDF)

Comparison of Body Temperature Measurements and the Clinical Symptoms Score System to Detect the Early Onset of the Anaphylaxis in Allergic Mice

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.S184-S184

2009

Volltextzugriff (PDF)

Sequential combined therapy with omalizumab and rituximab: a new approach to severe atopic dermatitis

Journal of investigational allergology & clinical immunology, 2013, Vol.23 (3), p.190-196

2013

Volltextzugriff (PDF)

Ability of Different Adjuvants to Modulate the Allergic Response to Olive Pollen

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S266-S266

2008

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)
Tagungsberichte
(4)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug Challenge Tests With General Anesthetics: Predictive Value of Skin Tests

Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response

Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Social Media as a Tool for the Management of Food Allergy in Children

Eosinophilic Esophagitis Caused by Grass Pollen Sublingual Immunotherapy With Tolerance to a Subcutaneous Extract

Is Self-injectable Epinephrine Being Used by Children With Food Allergy?

Differences in the Anaphylactic Response between C3H/HeOuJ and BALB/c Mice

One of the Faces of Facial Swelling: Melkersson-Rosenthal Syndrome

One of the Faces of Facial Swelling: Melkersson-Rosenthal Syndrome

Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients

Inhibition of Chronic Airway Inflammation and Remodeling by Galectin-3 Gene Therapy in a Murine Model

Characterization of allergens secreted by Anisakis simplex parasite: clinical relevance in comparison with somatic allergens

Angioedema Induced By Angiotensin-converting Enzyme Inhibitors: Two Cases Of Successful Treatment With A Novel B2 Bradykinin Antagonist

Preliminary study of the Craniofacial Pain and Disability Inventory-11: validation for patients with head and neck cancer

DNA-based immunotherapeutics for the treatment of allergic disease

Delayed Hypersensitivity Reaction to Lenalidomide: 2 Different Clinical Patterns in the Same Patient

Treatment satisfaction with AR101 oral immunotherapy for peanut allergy in a European paediatric population

ARTEMIS: A European, Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial of AR101 in Peanut-Allergic Children and Adolescents Aged 4-17

Anisakis Simplex and Ascaris Lumbricoides Inhibit the Allergic Response to Peanut in a Murine Model of Anaphylaxis

Allergic Response Modulation by Phytosterols in a Murine Model of Pollen Allergy

ARTEMIS: a European, Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial of AR101 in peanut-allergic children and adolescents aged 4-17 years

ARTEMIS: A European, phase 3, randomised, double-blind, placebo-controlled trial of AR101 in peanut-allergic children and adolescents aged 4-17

Comparison of Body Temperature Measurements and the Clinical Symptoms Score System to Detect the Early Onset of the Anaphylaxis in Allergic Mice

Sequential combined therapy with omalizumab and rituximab: a new approach to severe atopic dermatitis

Ability of Different Adjuvants to Modulate the Allergic Response to Olive Pollen

Suchergebnisse filtern